Skin cancer rates rocket 45% in 10 years
Rates have increased by more than a third (35%) for women and by almost three-fifths (55%) for men.
Read More
Tag: Own Your Tone
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
